SEARCH FOR DNA MARKERS LINKED TO MANIC DEPRESSIVE ILLNESS IN THE OLD ORDER AMISH

在旧秩序阿米什人中寻找与躁狂抑郁症相关的 DNA 标记

基本信息

项目摘要

We are carrying out a genome-wide search to identify chromosome regions that contain genes involved in bipolar affective disorder (BPAD, manic depressive illness). Approximately one percent of the population is afflicted by this severe recurrent mood disorder and untreated patients with BPAD have an approximately 20% risk of death from suicide. We are studying several large families from the Old Order Amish population where there is a very high incidence of BPAD over several generations. In these Old Order Amish families there may be a more limited number of different genes contributing to the affective disorder phenotype. In addition to the other reported linkages for BPAD, (i.e. to chromosomes 4p, 4q, 11,12,18q, 21,22 and X), our results suggest that genes on chromosome 6p SIBPAL (p<0.0001), chromosome 13 SIBPAL (p=0.0003), and chromosome 15 SIBPAL (p=0.0003), have roles in increasing the susceptibility to bipolar affective disorder. Also, rather than limiting our genome-wide search to identifying susceptibility loci for BPAD, we tested the hypothesis that protective alleles may contribute to the absence of psychiatric illness (i.e., mental health wellness) in unaffected family members in these high risk families. We found strong evidence for loci on chromosome 4p SIBPAL (p<0.00001; GENEHUNTER NPL=3.8) and 4q SIBPAL (p<0.001; GENEHUNTER NPL=4.7) that are linked to mental health wellness suggesting that certain alleles could prevent or modify the clinical manifestations of BPAD. The identification and characterization of susceptibility and protective alleles should lead to the development of more rational and direct approaches to effective therapy for affective disorders. - bipolar affective disorder, manic depressive illness, suicide, linkages, mental health wellness, susceptibility, protective alleles
我们正在进行全基因组搜索,以确定包含双相情感障碍(BPAD,躁狂抑郁症)相关基因的染色体区域。大约1%的人患有这种严重的复发性情绪障碍,未经治疗的BPAD患者有大约20%的自杀死亡风险。我们正在研究几个来自旧秩序阿米什人的大家庭,他们几代人的BPAD发病率非常高。在这些旧秩序阿米什家族中,可能有更有限数量的不同基因导致情感障碍表型。除了已报道的其他与BPAD相关的基因(即4p、4q、11,12,18q、21,22和X染色体)外,我们的研究结果表明,6p染色体上的基因SIBPAL (p<0.0001)、13染色体上的基因SIBPAL (p=0.0003)和15染色体上的基因SIBPAL (p=0.0003)在增加双相情感障碍的易感性中起作用。此外,我们并没有将我们的全基因组搜索限制在确定BPAD的易感性位点上,而是测试了保护性等位基因可能有助于这些高风险家庭中未受影响的家庭成员没有精神疾病(即心理健康)的假设。我们发现强有力的证据表明,4p染色体上的SIBPAL位点(p<0.00001; GENEHUNTER NPL=3.8)和4q染色体上的SIBPAL位点(p<0.001; GENEHUNTER NPL=4.7)与心理健康有关,这表明某些等位基因可以预防或改变BPAD的临床表现。易感性和保护性等位基因的鉴定和表征将导致开发更合理和直接的方法来有效治疗情感障碍。-双相情感障碍,躁狂抑郁症,自杀,联系,心理健康,易感性,保护性等位基因

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDWARD I GINNS其他文献

EDWARD I GINNS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDWARD I GINNS', 18)}}的其他基金

A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
  • 批准号:
    7340503
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
  • 批准号:
    7547743
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
  • 批准号:
    7752542
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
  • 批准号:
    7164431
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Novel Orally Administered Macrophage Delivered Gene Ther
新型口服巨噬细胞传递基因疗法
  • 批准号:
    7022537
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Glucocerebrosidase Gene Transfer to the Nervous System
葡萄糖脑苷脂酶基因转移至神经系统
  • 批准号:
    6642183
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
SEARCH FOR DNA MARKERS LINKED TO MANIC DEPRESSIVE ILLNESS IN THE OLD ORDER AMISH
在旧秩序阿米什人中寻找与躁狂抑郁症相关的 DNA 标记
  • 批准号:
    6111168
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TRANSGENIC ANIMAL MODELS OF HUMAN INHERITED DISORDERS
人类遗传性疾病的转基因动物模型
  • 批准号:
    6432827
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CORRECTION OF INHERITED PROTEIN DEFICIENCEIS BY GENE THERAPY
通过基因疗法纠正遗传性蛋白质缺陷
  • 批准号:
    6111134
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MOLECULAR GENETICS OF INHERITED NEUROLOGIC AND PSYCHIATRIC DISORDERS
遗传性神经和精神疾病的分子遗传学
  • 批准号:
    6111135
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
  • 批准号:
    486939
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
  • 批准号:
    486443
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship Programs
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
  • 批准号:
    486577
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
  • 批准号:
    2748645
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
  • 批准号:
    469571
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
  • 批准号:
    444068
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
  • 批准号:
    434675
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
  • 批准号:
    9555300
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
  • 批准号:
    10080262
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
  • 批准号:
    10588254
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了